Barr Cipro Generic Takes 50% Share; Erosion Slow Under Bayer Deal

Barr's generic ciprofloxacin has captured roughly half of Cipro prescriptions after five weeks on the market

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet